Complex and interconnected threats to global peace and security demands innovative and interconnected thinking by experts working across academic disciplines and industry sectors.
Influenza vaccines are recommended annually, but there’s now an increasing number of different vaccine types. Here’s what to know about this year’s shots.
The TGA has just approved a vaccine against RSV for Australians over 60. Here’s where protection is up to for the youngest children, who are also at risk from the virus.
The pandemic stretched our healthcare system to breaking point, but it also proved how new and positive models of screening and care can quickly be created in adversity.
Biometrics technology offers to cut the Gordian knot of passwords, usernames, PIN and QR codes, as well as passports and vaccine cards – but at what cost?
Australia’s COVID-19 vaccine rollout priority should move from those most at risk of the disease to those most likely to spread it, according to new modelling.
The case is growing stronger for COVID-19 vaccine mixing-and-matching, with recent data showing high efficacy and protection against SARS-CoV-2 virus strains.
Community pharmacies and pharmacists are important resources in Australia’s vaccine rollout, and right now they’re being under-utilised.
Australians will be able to show specific online proof if they’ve had two doses of a COVID jab.
Pharmacy students are underlining their value by taking their skills from the classroom to the COVID-19 frontline.
Australia has just embarked on a mass vaccination campaign, but historic measures will remain an important community safeguard.
When he volunteered to become one of the public faces of Victoria’s COVID-19 health response, Professor Allen Cheng’s life changed course dramatically – and accelerated.
Unprecedented efforts are driving the global push for a safe and effective COVID-19 vaccine. Here's how it's likely to be rolled out in Australia.
Two Monash students – and also firm friends – are on a mission to boost the uptake of the influenza vaccine.
We'll struggle to find a vaccine that works perfectly for people who need it most, despite what the headlines say is coming in 2021.
Early analysis suggests Pfizer's COVID-19 vaccine has an efficacy of more than 90%, but more data is still needed.
The spread of misinformation has striking parallels with the biological pandemic – and it, too, has cost lives.
The adjuvanted flu vaccine is free for over-65s and offers better protection than the standard vaccine. Here's what the research says.
Two free flu vaccines will improve protection for older people, but like those already available, they're not perfect.
Dummy text
